Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$524.17 +9.52 (+1.85%)
As of: Oct 21, 2026 · 3:10 PM EDT

Vertex Pharmaceuticals (VRTX) Other financing activities (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) reported Other financing activities of $4.3 million for Q2 2026, down 27.1% from $5.9 million a year earlier and down 98.1% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Other financing activities (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vertex Pharmaceuticals' Other financing activities came in at $326.3 million, down 11.2% year-over-year; for FY2025, it was $369.9 million, down 8.7% from FY2024.

  • Other financing activities has a five-year compound annual growth rate of 13.1% (FY2020 to FY2025).
  • By year, Other financing activities came in at $405 million in FY2024 (+79.1%), $226.1 million in FY2023 (+31.5%), $172 million in FY2022 (+26.6%) and $135.9 million in FY2021 (-32.2%).
  • Five-year quarterly Other financing activities spans a low of $1.7 million in Q4 2021 and a high of $270.5 million in Q1 2025.
  • Year over year, Other financing activities has now declined in each of the last three quarters, with growth averaging 1.1% over the last eight quarters.
  • The high point for year-over-year Other financing activities in five years was Q4 2024 (growth of 128.1%); the low point was Q2 2025 (a decline of 92.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $228.5 million (Q1 2026), $2.5 million (Q4 2025) and $91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Vertex Pharmaceuticals 132.90 Bn 104.91 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.90 Mn
Mar 31, 2026 -228.90 Mn
Dec 31, 2025 -1.40 Mn
Sep 30, 2025 -87.30 Mn
Jun 30, 2025 -6.50 Mn
Mar 31, 2025 -271.00 Mn
Dec 31, 2024 -6.40 Mn
Sep 30, 2024 -82.80 Mn
Jun 30, 2024 -79.60 Mn
Mar 31, 2024 -230.00 Mn
Dec 31, 2023 -4.70 Mn
Sep 30, 2023 -52.10 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -165.50 Mn
Dec 31, 2022 -1.00 Mn
Sep 30, 2022 -47.30 Mn
Jun 30, 2022 -4.00 Mn
Mar 31, 2022 -116.20 Mn
Dec 31, 2021 -6.00 Mn
Sep 30, 2021 -27.10 Mn
API Access

Vertex Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VRTX&period=max&api_key=YOUR_API_KEY